Thursday, December 13, 2012
Publication and contact
Insulin-like growth factor-2 (IGF-2)
peptide tag to improve enzyme replacement therapies to treat Pompe's disease
peptide tag may be useful for producing Pompe's disease enzyme replacement
therapies that have better tissue uptake than unmodified acid a-glucosidase (GAA).
A fusion protein consisting of a portion of IGF-2 linked to recombinant human
GAA was expressed in and purified from mammalian cells. In vitro, the
showed better uptake by rodent myoblasts than unmodified GAA. In a mouse
model of Pompe's disease, BMN-701 led to lower levels of glycogen in heart,
diaphragm and skeletal muscle than unmodified GAA. BMN-701 is in Phase I/II
testing to treat Pompe's disease, with topline data expected 1Q13.
are human recombinant GAA enzyme replacement therapies marketed by Sanofi's
Corp. unit to treat Pompe's disease (see Muscling up on
Myozyme, page 5).
Published online Dec. 13, 2012
licensing status undisclosed
Maga, J.A. et al. J.
Biol. Chem.; published online Nov. 27, 2012;
Contact: Jonathan H. LeBowitz, BioMarin Pharmaceuticals
Inc., Novato, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]